IgA Nephropathy Archives - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

FDA Approves Trutakna (Atacicept) for Adults with IgA Nephropathy

Voyxact Becomes First Biologic Approved for IgA Nephropathy as Competitors Advance

December 2, 2025

Redefining Autoimmune Kidney Disease Treatment Through Science-Led Innovation

August 26, 2025

Sibeprenlimab Shows 51% Reduction in Proteinuria in Pivotal IgAN Trial

Vanrafia (Atrasentan) Earns FDA Approval for IgAN, Achieved Proteinuria Reduction

Life Science Podcast

Combating Autoimmunity: Vera Therapeutics CEO Dr. Marshall Fordyce Discusses Advancing IgAN Treatments — Episode 202

Novartis’ Fabhalta (Iptacopan) Earns Third FDA Nod, This Time for C3G

Sibeprenlimab Reduces Proteinuria in Phase III IgA Nephropathy Trial

October 23, 2024

Advances in Rare Disease Drug Development: Disease Biology, Regulatory Support, Building Relationships and the Patient Voice